Sexual attraction existed in different cultures is controversial. Pheromones have been determined to play a role in sexual attraction between people. They influence gonadal hormone secretion, for example, follicle maturation in the ovaries in females and testosterone and sperm production in males. Research conducted by Donald G. Dutton and Arthur P. Aron in the 1970s aimed to find the relation between sexual attraction and high anxiety conditions. In doing so, 85 male participants were contacted by an attractive female interviewer at either a fear-arousing suspension bridge or a normal bridge. Conclusively, it was shown that the male participants who were asked to
Transgender hormone therapy (male-to-female) arousal would be inhibited; alternatively, if high doses of estrogen negatively impact sexual desire, which has been found in some research with cisgender women, it is hypothesized that combining androgens with high levels of estrogen would intensify this outcome. Unfortunately, to date there haven’t been any randomized clinical trials looking at the relationship between type and dose of transgender hormone therapy, so the relationship between them remains unclear. Typically, the estrogens given for male-to-female gender transition are 2 to 3 times higher than the recommended dose for HRT in postmenopausal women. Pharmacokinetic studies indicate taking these increased doses may lead